Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced it has entered into an R&D loan facility agreement with Paddington St Finance. The maximum loan value of the facility is the lesser of $2 million or 80% of the estimated refundable tax offset credits under the ATO's R&D tax incentive.
Because of a few poignant questions on yesterday's significant Queensland Bauxite (ASX:QBL) announcement there are dominating queries sent to the Company that obviously need clarification.
Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.
Pnina Feldman's Queensland Bauxite Limited (ASX:QBL) has announced today that QBL is undertaking a significant transformation of the Company from a mining exploration company with a Medical Cannabis subsidiary to a new major global Cannabis player through a 100% merger of its 55% owned subsidiary, Medical Cannabis Limited and the new 100% acquisition of Medcan Australia.
The Board of Queensland Bauxite Limited (ASX:QBL) is excited to announce that the Company and its subsidiary, Medical Cannabis Limited have entered into a legally binding heads of agreement to acquire a 100% interest in Medcan Australia Pty Ltd.
Oventus Medical Ltd (ASX:OVN) is pleased to provide a copy of its latest newsletter for investors.
The Board of Queensland Bauxite Limited (ASX:QBL) is delighted to announce that the ASX has approved the Company's Announcement to be released. The Company intends to release the announcement on Thursday 21 June 2018. QBL will recommence trading on the ASX following the release of the Announcement.
